Let's see: We have one opinion saying NMA is "dead", another opinion saying thousands of engineers are now working on NMA and it will gain ATO some time in 2020.
This reminds me so much of classic a.net from a decade or so, and that's a good thing.
astuteman wrote:I believe it is a structural characteristic of the market between narrowbodys and widebodys that won't disappear.
I have always thought it was folly for Boeing to launch a dedicated all new model at the space.
Thanks as always for the thoughtful post.
I guess that's the place where things get polarized. We've had dozens of posts arguing back and forth about the value proposition claimed by NMA, that one could build an ovoid tight mid range wide body and end up with production and trip costs closer to traditional narrow bodies rather than traditional wide bodies, that this would allow more routes to be opened, that Boeing could capture more life cycle profit to make the business case close, etc.
astuteman wrote:FSA might not sound too adventurous, but properly executed, Boeing could do to the NEO what the NEO has done to the MAX, by giving it the flexibility to have bigger diameter engines and longer fuselages - e.g. longer landing gear, wider aisle, potential for folding wingtips.
A strategy of launching an initial FSA model that is, say, a tiny bit bigger than the A321, and thus slightly differentiated is a starting point, and I think would lead to volumes that NMA will never see.
This could be followed by a bigger model going further into NMA space than the A320NEO family is able to go.
I'm not sure the metric for FSA to chase is more sales volume than NMA. I would think it is to produce more value thus profit per sale.
I think the business case for the FSA is harder to close because it is at best an incremental improvement over current A321, and Airbus has all kinds of approaches to attacking that, be it through the tech we've read they're already developing ( CFRP wing box, CFRP wing, stretch ) not to mention simply undermining it by lowering prices.
astuteman wrote:The 737-8 could be left intact for now - it is easily the most popular MAX, and eventually replaced by a smaller FSA model at a time that is convenient to Boeing
This FSA would ultimately achieve the "commoditisation" that you rightly characterised some time ago, and would put the monkey back on Airbus.
Airbus would then have the choice of
a) the NEO becoming the new MAX
b) launching a new product
Just thoughts.
But I think there is a strategy route through for Boeing that can move them back onto the front foot.
I think if your thoughts about the actual need for A321 being the core model rather than the XLR are correct then we should see 737-10 gain more traction after its EIS. I think 737-10 will be more successful than many here assume.
I don't see how spending non-incremental amounts of money to develop a clean sheet with incremental advantages to enter a market with a healthy incumbent with a strong desire to defend its turf is going to be a winning strategy. I don't see how aiming just a bit bigger than A321 provides enough of a differentiation to convince airlines that are already A321 operators to take in a whole new fleet type. I can see how NMA could make such an argument presuming it can produce much of the gains Boeing has claimed for it. For instance both DL and QF CEOs have been quoted supporting the NMA concept despite both having already purchased A321s. I doubt they'd be as supportive of FSA since it is almost completely overlapped by A321. I am dubious that NMA can produce the gains Boeing has claimed, but have not ruled that out to the degree some here have.
scbriml wrote:Why hasn't Boeing been able to close the business case on something they've been studying for years? What are you seeing that they've missed? By all accounts, they seem to be moving further away from closing the business case, not closer.
Yes, that's the "inconvenient truth" for the NMA case. I suspect they are seeing they cannot squeeze the supply chain to the degree they thought they could ("Partnership for Success 2" is said to be dead) and the projected sales volume for NMA simply does not provide the kind of ROI they want. Add to that the MAX tragedy and the regime change (McAllister gone, Deal installed) and there definitely is a re-think going on, or if nothing else, simple procrastination since they are not getting the results they think they need.
Keep in mind RA's article also included the default "do nothing" clause. I think it's at least as viable as NMA and FSA.
Both A and B have said they don't see any compelling tech that would make them want to produce a new narrow body till 2030 or so. The fact that A321 has dominated its market segment has not changed that.
The worst case for Boeing is it could choose to spend big on FSA using 2020 era tech, hit the market in the late 2020s right as most airlines say we have all the A321-A322 sized airplanes we need thank you very much and finds itself having to spend big on a smaller narrow body because that is now the hot market.segment.
A "do nothing" approach would concede the A321 space for this generation, let the MAX make whatever sales it can make for a few more years, but then do a true 737 family replacement from 150-250 seats rather than focusing on 220 and above.
I know that conceding a market segment will strike some as absurd, but the reality is you can't be best of breed every where all the time, and spending big just to end up being late to the party may be the worst possible outcome.
mjoelnir wrote:There is an economical and operational biggest single aisle frame and an economical and operational smallest dual aisle frame. Between them is the gap.
Counting up the models, you can throw out a few. The 757-200 is replaced, both in capacity and range.
Than we have the 757-300, 55 frames sold, the 767-200/200ER, 249 frames sold, the A310, 255 frames sold. the 767-300 managed 687 and the A300 has 561. The 767-400 had just 38 sales.
It is an impressive number of models, but apart from the 767-300 and A300, non of them a roaring success.
There is also the point, that quite a few frames counted up, do not fit the NMA narrative and were not bought to fill this gap. The example would be the 767-300ER, bought often for its range, before the A330-200 came around.
The only frame that seem to be designed to fit this gap, the A300, the pioneering first twin aisle wide body frame, a short to medium haul airliner, was perhaps designed without thinking about this gap. The A300 was constrained in size and range by the available engines.
So I have my big doubts for the feasibility for a clean sheet program in this gap.
I have my doubts for the feasibility for a clean sheet program in this gap but they don't come from looking at airliners that entered the market in the 70s/80s/90s. The past is not prologue.
The main questions I have are around the business case, as always. If you can say there is no gap for NMA due to A321, then you should also be able to say there is no gap for FSA due to A321. You have to skate to where the puck will be, not where it is right now. As above all three of the big US 3 have A321neo on order. Who is going to order a A321 sized FSA for EIS in 2028 or so when they can take the path of least risk and least cost and order more A321s? IMO at least NMA offers payload/range that A321 won't meet without a big spend from Airbus and gives Boeing a chance at a first mover's advantage.
Suppose FSA was to be offered by end 2020, a narrowbody product range covering 739-A322 sizes for EIS in 2028: Who is the launch customer, and how many launch orders does it get? What does it do to the existing MAX backlog due to customers demanding to move orders to the new plane?
flee wrote:mjoelnir wrote:The only frame that seem to be designed to fit this gap, the A300, the pioneering first twin aisle wide body frame, a short to medium haul airliner, was perhaps designed without thinking about this gap. The A300 was constrained in size and range by the available engines.
So I have my big doubts for the feasibility for a clean sheet program in this gap.
We are in the same situation today - there is a lack of available engines for NMA. Any clean sheet project launched today can only expect the first aircraft to be delivered in about 8-10 years.
I don't know about that. The aviation media told us that all three engine vendors were interested in bidding on the NMA engine, Boeing accepted proposals at end 2019, RR dropped out but PW and CFM made proposals. I bet these are derivatives of GTF and LEAP respectively, so they won't be 8-10 year programs.
dtw2hyd wrote:If some airline wants a plane to fill the MOM-gap as explained, a heavily discounted 788 with derated engines can close the deal. The loss on discount would be trivial compared to $$Billions wasted on developing a clean sheet MOM.
To me this reads like Airbus saying they could compete with 777 by selling heavily discounted A346 with compensation payments for excess fuel costs, which was a losing strategy.
I can't think of a time where this "square peg in round hole" approach has worked out, can you?
As above, this all comes down to how convinced you are that the ovoid NMA can or cannot produce production and per trip economics close to narrow bodies, which is the main premise for NMA.
Some here are convinced that it cannot thus NMA will never produce an economic advantage, others here are convinced otherwise, others sit on the fence.
I would have to say Boeing's reluctance to offer the product suggests it's more of a challenge than they originally thought.